Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Securities Suit Over Inspire V Rollout

Overview

• The federal class action, filed in the U.S. District Court for the District of Minnesota, is captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 0:25-cv-04247.
• Plaintiffs cite Medicare claims-processing software updates that allegedly took effect only on July 1, 2025, which they say prevented billing earlier in the rollout.
• The complaint alleges many implanting centers were not fully trained or onboarded and that surplus inventory of the prior Inspire IV device depressed demand for Inspire V.
• On August 4, 2025, Inspire disclosed rollout delays and sharply cut 2025 EPS guidance by more than 80%, followed by a one-day share decline of about 32% to $87.91, erasing roughly $1.2 billion in market value.
• Multiple investor law firms, including Hagens Berman, Rosen, Faruqi & Faruqi, and Bleichmar Fonti & Auld, are soliciting investors for lead-plaintiff roles under Sections 10(b) and 20(a), and no class has been certified.